S. Bassil et al., In vitro fertilization outcome according to age and follicle-stimulating hormone levels on cycle day 3, J AS REPROD, 16(5), 1999, pp. 236-241
Purpose: In a retrospective study, the prognostic factors of in vitro ferti
lization outcome were studied in women of 39 years of age or older; with an
elevated cycle day 3 follicle-stimulating hormone (FSH) level.
Methods: Ovarian stimulation was achieved with a combination of gonadotropi
n-releasing hormone agonist/human menopausal gonadotropin in a short protoc
ol. All patients underwent FSH dosage on cycle day 3 prior to stimulation.
The pregnancy rate was studied according to age, FSH levels, and stimulatio
n parameters.
Results: There was a negative correlation between day 3 FSH levels and the
number of ovocytes retrieved. Cycles canceled because of the absence of ova
rian response had a significantly higher mean FSH value (18.2 mlU/ml) than
cycles ending in ovocyte retrieval (14.6 mlU/ml). Patients with three or mo
re growing follicles during stimulation achieved a significantly higher pre
gnancy rate per egg retrieval (16%) compared to patients with fewer than th
ree growing follicles (6%). Eighty percent of those pregnancies were obtain
ed during the first two IVF cycles. Even with an elevated FSH level, some p
atients developed three or more follicles after stimulation. In such cases,
the number of embryos available for transfer was the only significant limi
ting factor to achieving pregnancy.
Conclusions: As our results suggest, there is a discrepancy between biologi
cal and chronological ovarian age. In patients with art elevated cycle day
3 FSH level and over 40 years of age, alternatives to fertility treatments
(ovum donation, adoption, or no treatment) should not be considered as firs
t choices. Indeed, even with elevated FSH levels, a 16% pregnancy rate per
egg retrieval may be obtained if three or more growing follicles can be see
n during ovarian stimulation. However, in the presence of fewer than three
growing follicles during ovarian stimulation, the patient should be informe
d about the discouraging prognosis of the running cycle.